340B Rebate Plan Sparks Questions On Enforcement, Appeals
By Dan McKay · August 12, 2025, 4:08 PM EDT
The Trump administration's plan to test a post-sale rebate model for the 340B drug discount program will require drugmakers to explain why they denied a rebate....
To view the full article, register now.
Try a seven day FREE Trial
Already a subscriber? Click here to login